Cargando…

An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion

Detalles Bibliográficos
Autores principales:	Cheaney, Barry, Bowden, Stephen, Krause, Katie, Sloan, Emily A., Perry, Arie, Solomon, David A., Han, Seunggu Jude, Wood, Matthew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617605/ https://www.ncbi.nlm.nih.gov/pubmed/31288852 http://dx.doi.org/10.1186/s40478-019-0763-x

Ejemplares similares

Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
por: Tang, Vivian, et al.
Publicado: (2023)

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020)

CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review
por: Yuile, Alexander, et al.
Publicado: (2023)

Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas
por: Marker, Daniel F., et al.
Publicado: (2020)

Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2020)

Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
por: Huang, L. Eric
Publicado: (2022)

Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history
por: Chan, Andrew K., et al.
Publicado: (2017)

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma
por: Funakoshi, Yusuke, et al.
Publicado: (2021)

MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
por: Yanagisawa, Shunsuke, et al.
Publicado: (2021)

P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
por: Vij, Meenakshi, et al.
Publicado: (2023)

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy
por: Grard, Marion, et al.
Publicado: (2021)

SDPS-27 P16 IMMUNOHISTOCHEMISTRY AS A SCREENING TOOL FOR HOMOZYGOUS CDKN2A DELETIONS IN GLIAL TUMORS
por: Zschernack, Valentina, et al.
Publicado: (2023)

Co‐occurrence of CDKN2A/B and IFN‐I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma
por: Peng, Yuan, et al.
Publicado: (2022)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

The Evolving Role of the Oncologic Neurosurgeon: Looking Beyond Extent of Resection in the Modern Era
por: Bowden, Stephen G., et al.
Publicado: (2018)

HGG-08. COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION
por: Mayr, Lisa, et al.
Publicado: (2023)

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
por: Maelandsmo, G. M., et al.
Publicado: (1995)

Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to ‘Polymorphous low-grade neuroepithelial tumor of the young’
por: Gupta, Rohit, et al.
Publicado: (2021)

Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis
por: Ortiz, Berenice, et al.
Publicado: (2014)

A case of recurrent epilepsy‐associated rosette‐forming glioneuronal tumor with anaplastic transformation in the absence of therapy
por: Halfpenny, Aaron, et al.
Publicado: (2019)

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene
por: Carén, Helena, et al.
Publicado: (2008)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

A glioneuronal tumor with CLIP2-MET fusion
por: Chowdhury, Tamrin, et al.
Publicado: (2020)

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival
por: Barresi, Valeria, et al.
Publicado: (2021)

Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study
por: Park, Yae Won, et al.
Publicado: (2023)

Gliosarcoma With Glioneuronal and Rhabdomyosarcoma Components
por: Alturkustani, Murad
Publicado: (2022)

Diffuse Leptomeningeal Glioneuronal Tumour
por: Saliba, Tom, et al.
Publicado: (2023)

CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma
por: Qiao, Juanli, et al.
Publicado: (2021)

The clinical and pathological features of low-grade epilepsy-associated glioneuronal tumors
por: Xie, Mingguo, et al.
Publicado: (2022)

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
por: Lesueur, F, et al.
Publicado: (2008)

Focal Epilepsy Associated with Glioneuronal Tumors
por: Loiacono, Giulia, et al.
Publicado: (2011)

Case Report: Unusual High-Grade Diffuse Leptomeningeal Glioneuronal Tumor Mimicking Tuberculous Meningitis in a Child From an Endemic Region
por: Teh, Yong Guang, et al.
Publicado: (2021)

An Individual Patient Data Meta-Analysis on Characteristics and Outcome of Patients with Papillary Glioneuronal Tumor, Rosette Glioneuronal Tumor with Neuropil-Like Islands and Rosette Forming Glioneuronal Tumor of the Fourth Ventricle
por: Schlamann, Annika, et al.
Publicado: (2014)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
por: Genescà, E., et al.
Publicado: (2018)

Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas
por: Kocakavuk, Emre, et al.
Publicado: (2023)

Rosette-forming glioneuronal tumor of the fourth ventricle
por: Kumar, Manoj, et al.
Publicado: (2015)

Papillary Glioneuronal Tumour: A Case Report
por: Rocka, Saulius, et al.
Publicado: (2019)

Rare Neuronal, Glial and Glioneuronal Tumours in Adults
por: Crainic, Nicolas, et al.
Publicado: (2023)

Craniofacial Defects in Embryos with Homozygous Deletion of Eftud2 in Their Neural Crest Cells Are Not Rescued by Trp53 Deletion
por: Beauchamp, Marie-Claude, et al.
Publicado: (2022)

Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
por: Kurozumi, Kazuhiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6u8muttgr9spcoioarc6fhrj0u